September 2004
Advertisement
Advertisement
Trending on HCPLive
1
Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment
2
Saroglitazar Targets Bile Acid Dysregulation, Inflammation in PBC, With Raj Vuppalanchi, MD
3
MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins
4
Long-Term Insulin Resistance Tied to CT Measures of Interstitial Lung Disease
5